Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
- Hair loss
- Health & Fitness
- cell therapy
- Stem cells
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 110284
Celution 800/CRS Device An automated, electromechanical device containing multilingual, interactive software that facilitates the extraction and concentration of ADRCs, using validated algorithms programmed into the deviceâ€™s software, standardizing tissue disaggregation, centrifugation and therapeutic- specific processes.
Celution 805/CRS Consumable Set A sterile, single-use set used with the Celution Device to process tissue and extract ADRCs within a closed system.
IPSCIO Record ID: 7508
Celution 800/IV Device – An automated, electromechanical device containing multilingual, interactive software that facilitates the extraction and concentration of ADRCs, using validated algorithms programmed into the deviceâ€™s software, standardizing tissue disaggregation, centrifugation and therapeutic- specific processes.
Celution 805/IV – Consumable Set A sterile, single-use set used with the Celution Device to process tissue and extract ADRCs within a closed system.
Celase Reagent – CelaseÂ® is a proprietary enzyme blend that releases ADRCs from the extracellular matrix of adipose tissue, optimized for use with the Celution device and consumable set. Celase is a sterile, pharmaceutical grade, mammalian-free reagent that is manufactured in compliance with Good Manufacturing Practices (GMP) standards.
Intravase Reagent or Reagent B – IntravaseÂ® is a sterile, GMP-grade secondary reagent used with the Celution System to prepare the Celution cell output for safe intravascular delivery. Intravase is a highly purified product to assure the lowest levels of impurities. Intravase is provided as a single-use unit which consists of a clear glass vial within a protected canister.
200/CK Convenience Kit – 200/CK Procedure Pack contains all necessary components for a single Celution procedure, including ancillary products for tissue collection, tissue processing, and delivery. The ready-to-use components are single-use, minimizing the risk of contamination for patients, healthcare staffs, surgeons, and system operators.
530/IS Tissue Collection Instrument Set – The Tissue Collection Instrument Set contains a collection of autoclavable components required for liposuction (200-360mL of tissue) under local anesthesia using a hand-held syringe.
IPSCIO Record ID: 4462
ADRC Enriched Applications includes any sale or use of the Standalone Fat Transplantation Products for the express purpose of mixing ADRCâ€™s with Standalone Fat Transplantation Product processed fat tissue for re-implantation of the tissue into a patient.
The Parties Agree that Licensee may not sell the Standalone Fat Transplantation Products separately, but may only offer the Standalone Fat Transplantation Products in conjunction with a Celution consumable set, whether packaged together, or bundled with one or more separately packaged products (including the consumable set).
IPSCIO Record ID: 260432
The purpose of this agreement is to establish ADRC Banking facilities for the acquisition, storage and retrieval of ADRCs exclusively using Licensorâ€™s technology, including the CelutionTM device and related products and disposables in the country of Japan.
Licensee shall purchase all CelutionTM devices, consumables, enzymes, harvest kits and software, collectively the device, directly from Licensor.
The Licensor Material shall include the Devices, the Packages, the Services, Licensor IP, Licensor Regulatory Information and Licensors Confidential Information.
ADRC refers to a proprietary, state-of-the-art system for adipose-derived stem and regenerative cell harvesting, processing, cryopreservation, storage, and retrieval banking that is useful in hospital settings, and Licensor has acquired and possesses certain intellectual property rights pertaining to stem and regenerative cell technology, including devices, products and services used in connection with ADRCs.
The field of use is solely for the purposes of (cell) Banking in the Territory.
IPSCIO Record ID: 273421
With this amendment, The University Regents grant a world-wide license under The Universitys undivided interest in Patent Rights to make, have made, use, sell, offer to sell and import Product and to practice Licensed Method in the Field.
The patents include Isolation of Stromal Cells from Adipose Tissue, Isolation of Mesenchymal Stem Cells from Adipose Tissue, and, Adipose-Derived Stem Cells and Lattices.
Product means Research Product and Clinical Product.
Licensee is commercializing an automated device called Celution, which when operated in conjunction with various disposable component parts is capable of producing a heterogeneous isolate of the material naturally occurring in adipose tissue including unmodified amounts of stem cells and other regenerative cells, intended for human therapeutic, diagnostic, cosmetic and other uses.
The patented CelutionÂ® family of products process patientsâ€™ adipose-derived stem and regenerative cells (ADRCs) at the point of care. The CelutionÂ® family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzymes, and related instrumentation. Licensee commercialization model is based on the sale of CelutionÂ® Systems and on generating recurring revenues from the single-use consumable sets.
Commercial activities are currently focused on cosmetic and reconstructive surgery in Europe and Asia-Pacific, where Cytoriâ€™s core product, the CelutionÂ® System, provides physicians with clinical grade stem and regenerative cells.
IPSCIO Record ID: 383570
The patents are
— Prostaglandin D2 Synthase and its Products as Cause of Hair Loss and Target for Therapy;
— Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.